1
Clinical Trials associated with Rabies vaccine(Novartis Vaccines)A Phase II, Pilot, Randomized, Open-Label, Single-Center Study to Evaluate Immunogenicity, Safety and Booster Response of 3 Full Intramuscular Doses Versus 3 Half Intramuscular Doses Versus 3 Intradermal Doses Versus 2 Intradermal Doses of PCEC Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine as a Pre-Exposure Regimen in 12 to 18 Months Old Toddlers in Thailand.
This study evaluated the safety and immunogenicity of rabies vaccine and Japanese encephalitis vaccine in toddlers. All children developed adequate immune responses. Rabies vaccination with PCECV did not interfere with the antibody response to Japanese encephalitis vaccine. The rabies vaccine PCECV and Japanese encephalitis vaccine are safe and immunogenic when administered concomitantly to toddlers.
100 Clinical Results associated with Rabies vaccine(Novartis Vaccines)
100 Translational Medicine associated with Rabies vaccine(Novartis Vaccines)
100 Patents (Medical) associated with Rabies vaccine(Novartis Vaccines)
100 Deals associated with Rabies vaccine(Novartis Vaccines)